Doximity, Inc. (NASDAQ:DOCS) Shares Sold by Hillsdale Investment Management Inc.

Hillsdale Investment Management Inc. decreased its position in shares of Doximity, Inc. (NASDAQ:DOCS) by 10.8% during the 1st quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 14,890 shares of the company’s stock after selling 1,800 shares during the quarter. Hillsdale Investment Management Inc.’s holdings in Doximity were worth $401,000 at the end of the most recent quarter.

Other large investors also recently bought and sold shares of the company. First Horizon Advisors Inc. increased its stake in shares of Doximity by 111.3% during the 4th quarter. First Horizon Advisors Inc. now owns 995 shares of the company’s stock worth $28,000 after purchasing an additional 524 shares in the last quarter. GAMMA Investing LLC acquired a new stake in Doximity in the 4th quarter valued at $40,000. Essex Investment Management Co. LLC purchased a new position in Doximity in the first quarter valued at about $73,000. Central Pacific Bank Trust Division acquired a new position in shares of Doximity during the first quarter worth about $120,000. Finally, Jump Financial LLC purchased a new stake in shares of Doximity in the fourth quarter worth about $202,000. Institutional investors and hedge funds own 87.19% of the company’s stock.

Analysts Set New Price Targets

DOCS has been the topic of several recent research reports. Morgan Stanley reissued an “underweight” rating and set a $25.00 price target on shares of Doximity in a research report on Tuesday, April 23rd. Evercore ISI upped their price objective on shares of Doximity from $28.00 to $29.00 and gave the company an “in-line” rating in a research report on Friday, May 17th. Wells Fargo & Company lowered Doximity from an “equal weight” rating to an “underweight” rating and dropped their target price for the stock from $27.00 to $19.00 in a research report on Thursday. William Blair reiterated an “outperform” rating on shares of Doximity in a research note on Friday, May 17th. Finally, JPMorgan Chase & Co. upgraded Doximity from an “underweight” rating to a “neutral” rating and set a $25.00 price objective on the stock in a report on Thursday, April 25th. Two equities research analysts have rated the stock with a sell rating, ten have assigned a hold rating and three have assigned a buy rating to the company’s stock. According to data from MarketBeat.com, the stock presently has an average rating of “Hold” and a consensus target price of $28.00.

Insider Buying and Selling at Doximity

In other news, Director Kira Scherer Wampler sold 2,500 shares of the company’s stock in a transaction on Friday, May 17th. The shares were sold at an average price of $27.22, for a total value of $68,050.00. Following the transaction, the director now directly owns 10,258 shares of the company’s stock, valued at $279,222.76. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. In related news, Director Kira Scherer Wampler sold 2,500 shares of the business’s stock in a transaction that occurred on Friday, May 17th. The stock was sold at an average price of $27.22, for a total value of $68,050.00. Following the completion of the sale, the director now owns 10,258 shares of the company’s stock, valued at approximately $279,222.76. The sale was disclosed in a document filed with the SEC, which is available at this link. Also, Director Timothy S. Cabral sold 10,000 shares of the firm’s stock in a transaction that occurred on Wednesday, June 12th. The shares were sold at an average price of $30.00, for a total transaction of $300,000.00. Following the transaction, the director now directly owns 10,258 shares in the company, valued at approximately $307,740. The disclosure for this sale can be found here. Insiders sold 46,500 shares of company stock valued at $1,373,825 in the last quarter. Company insiders own 39.40% of the company’s stock.

Doximity Stock Up 1.9 %

NASDAQ DOCS traded up $0.55 on Monday, reaching $28.77. 1,114,601 shares of the stock traded hands, compared to its average volume of 1,680,796. The firm’s fifty day simple moving average is $27.79 and its 200 day simple moving average is $27.47. The company has a market cap of $5.33 billion, a price-to-earnings ratio of 39.96, a P/E/G ratio of 5.28 and a beta of 1.22. Doximity, Inc. has a 12 month low of $19.71 and a 12 month high of $36.03.

Doximity (NASDAQ:DOCS) last posted its quarterly earnings data on Thursday, May 16th. The company reported $0.20 EPS for the quarter, beating analysts’ consensus estimates of $0.16 by $0.04. The company had revenue of $118.06 million during the quarter, compared to analyst estimates of $116.46 million. Doximity had a net margin of 31.04% and a return on equity of 17.44%. As a group, equities research analysts forecast that Doximity, Inc. will post 0.74 EPS for the current fiscal year.

Doximity Profile

Doximity, Inc operates a cloud-based digital platform for medical professionals in the United States. The company's platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers.